SCYNEXIS (SCYX) Should Be Up, Now Down on Good Phase 3 Readout - Maxim Group
Tweet Send to a Friend
Maxim Group analyst Jason McCarthy reiterated a Buy rating and $4.00 price target on SCYNEXIS (NASDAQ: SCYX), saying shares should ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
